NDC Package 0078-1021-91 Vijoice

Alpelisib Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

0078-1021-91

Package Description:

1 BLISTER PACK in 1 CARTON / 28 TABLET in 1 BLISTER PACK (0078-1021-90)

Product Code:

0078-1021

Proprietary Name:

Vijoice

Non-Proprietary Name:

Alpelisib

Substance Name:

Alpelisib

Usage Information:

This medication is used to treat certain types of breast cancer. Alpelisib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells.

11-Digit NDC Billing Format:

00078102191

NDC to RxNorm Crosswalk:

RxCUI: 2169310 - alpelisib 200 MG Oral Tablet

RxCUI: 2169316 - alpelisib 50 MG Oral Tablet

RxCUI: 2169319 - {28 (alpelisib 200 MG Oral Tablet) / 28 (alpelisib 50 MG Oral Tablet) } Pack

RxCUI: 2169319 - alpelisib 200 MG (28) Oral Tablet / alpelisib 50 MG Oral Tablet (28) Oral Tablet, 250 MG Daily Dose Pack

RxCUI: 2598459 - Vijoice 50 MG Oral Tablet

Product Type:

Human Prescription Drug

Labeler Name:

Novartis Pharmaceuticals Corporation

Dosage Form:

Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.

Administration Route(s):

Oral - Administration to or by way of the mouth.

Active Ingredient(s):

ALPELISIB 50 mg/1

Sample Package:

Yes

FDA Application Number:

NDA215039

Marketing Category:

NDA - A product marketed under an approved New Drug Application.

Start Marketing Date:

04-05-2022

Listing Expiration Date:

12-31-2024

Exclude Flag:

Code Structure:

0078 - Novartis Pharmaceuticals Corporation
- 0078-1021 - Vijoice
  - 0078-1021-91 - 1 BLISTER PACK in 1 CARTON / 28 TABLET in 1 BLISTER PACK (0078-1021-90)

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
0078-1021-84	1 BLISTER PACK in 1 CARTON / 28 TABLET in 1 BLISTER PACK (0078-1021-51)

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0078-1021-91?

The NDC Packaged Code 0078-1021-91 is assigned to a package of 1 blister pack in 1 carton / 28 tablet in 1 blister pack (0078-1021-90) of Vijoice, a human prescription drug labeled by Novartis Pharmaceuticals Corporation. The product's dosage form is tablet and is administered via oral form.

Is NDC 0078-1021 included in the NDC Directory?

Yes, Vijoice with product code 0078-1021 is active and included in the NDC Directory. The product was first marketed by Novartis Pharmaceuticals Corporation on April 05, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 0078-1021-91?

The 11-digit format is 00078102191. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
4-4-2	0078-1021-91	5-4-2	00078-1021-91

Table of Contents